The catholic university of Korea, seoul ST.Mary's hospital
Welcome,         Profile    Billing    Logout  
 22 Trials 
25 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chung, Woo-Young
IRIS FFR, NCT01366404: Study of the Natural History of FFR Guided Percutaneous Coronary Intervention

Recruiting
N/A
20000
RoW
Seung-Jung Park, CardioVascular Research Foundation, Korea, Abbott Medical Devices
Coronary Artery Disease
04/37
04/37
IRIS-MAIN, NCT01341327: Observational Study for Left Main Disease Treatment

Recruiting
N/A
10000
RoW
Seung-Jung Park, CardioVascular Research Foundation, Korea
Coronary Artery Disease
12/32
12/33
Kim, Sung Soo
REMBRANDT, NCT04700436: Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia

Recruiting
4
240
RoW
Rosuzet tablet 10/5 mg (Ezetimibe 10 mg/Rosuvastatin 5 mg), Suvast tablet 10 mg (Rosuvastatin 10 mg)
Seoul National University Hospital, Gangnam Severance Hospital
Endocrine System Diseases, Nutritional and Metabolic Diseases, Diabetes Mellitus, Type 2, Dyslipidemias
05/21
11/21
ABX464-105, NCT05507203: ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Recruiting
3
612
Europe, Canada, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
03/25
04/25
HER2CLIMB-05, NCT05132582 / 2021-002491-39: A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer

Active, not recruiting
3
654
Europe, Canada, Japan, US, RoW
Tucatinib, TUKYSA, ONT-380, ARRY-380, Trastuzumab, Herceptin, Herceptin Hylecta, Pertuzumab, Perjeta, Combination product: Trastuzumab + Pertuzumab, Phesgo, Placebo
Seagen Inc., Merck Sharp & Dohme LLC
HER2 Positive Breast Cancer
05/25
10/27
ABTECT, NCT05535946: - Maintenance

Recruiting
3
1050
Europe, Canada, Japan, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
01/26
01/30
NRG-HN005, NCT03952585: De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

Active, not recruiting
2/3
384
Canada, US
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Fludeoxyglucose F-18, 18FDG, FDG, Fludeoxyglucose (18F), fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, Image Guided Radiation Therapy, IGRT, image-guided radiation therapy, Image-Guided Radiotherapy, Intensity-Modulated Radiation Therapy, IMRT, Intensity modulated radiation therapy (procedure), Intensity Modulated RT, Intensity-Modulated Radiotherapy, Radiation, Intensity-Modulated Radiotherapy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
National Cancer Institute (NCI), NRG Oncology
Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Oropharyngeal Squamous Cell Carcinoma, Papillary Squamous Cell Carcinoma, Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Squamous Cell Carcinoma
03/24
12/25
NCT04696120: Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial

Not yet recruiting
2
200
RoW
Apixaban, apixaban 5mg or 2.5mg bid, Placebo, placebo bid
Korea University Guro Hospital, Dt&Sanomedics
Heart Failure, Sinus Rhythm, Cerebrovascular Disease
08/22
02/23
NCT02630069: CDP-choline Treatment in ATS Users

Recruiting
2
160
RoW
CDP-choline, Placebo, Supportive psychotherapy
Ewha Womans University Mokdong Hospital
Substance Use Disorders
12/22
12/22
NCT03062059: The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence

Recruiting
2
134
RoW
Intravesical 2000mg/52.6ml gemcitabine instillation, Gem Tan inj (liquid), Normal saline
National Cancer Center, Korea, Samsung Medical Center, Asan Medical Center, Seoul National University Hospital, Korea University Anam Hospital, Chong Kun Dang Pharmaceutical Corp.
Urothelial Carcinoma
12/22
12/22
ERTEMIS, NCT05540587: Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis

Recruiting
2
240
RoW
Edoxaban, Warfarin
Sung-Hwan Kim, Daiichi Sankyo Korea Co., Ltd.
Mitral Valve Stenosis, Atrial Fibrillation, Stroke, Systemic Embolism
05/24
05/26
SGNDV-005, NCT06003231: A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Recruiting
2
160
Europe, Canada, US, RoW
disitamab vedotin, RC48, RC48-ADC
Seagen Inc.
Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms
05/26
05/28
NCT06051747: Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea)

Active, not recruiting
1/2
1
RoW
Three-dimensional patient-specific bioprinting trachea implantation
Ja Seong Bae, MD, phD, Korea Health Industry Development Institute
Thyroid Cancer
08/23
08/25
ELEVATE, NCT05563220: Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting
1/2
400
Europe, US, RoW
Elacestrant, Alpelisib, Piqray, Everolimus, Afinitor, Ribociclib, Kisqali, Palbociclib, Ibrance, Capivasertib, Truqap, Abemaciclib, Verzenio
Stemline Therapeutics, Inc.
Breast Cancer, Metastatic Breast Cancer
12/24
08/26
SHR-A2009-I-101, NCT05114759: A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors

Recruiting
1
132
Japan, RoW
SHR-A2009
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Advanced Solid Tumors
12/23
12/24
NCT06638307: A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

Recruiting
1
124
Europe, US, RoW
MEN2312, Elacestrant
Stemline Therapeutics, Inc.
Advanced Breast Cancer
10/25
10/26
Reasoning, NCT06373172: Enhancing Clinical Competency

Completed
N/A
37
RoW
virtual simulation-based education program
Tongmyong University
Clinical Reasoning, Communication, Development, Human
06/20
03/23
RESAR, NCT03838718: REtroperitoneal SArcoma Registry: an International Prospective Initiative

Recruiting
N/A
2000
Canada, US, Europe, RoW
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, TransAtlantic Retroperitoneal Sarcoma Working Group
Retroperitoneal Sarcoma
12/20
12/30
NCT06423742: Consecutive Dual-Session tDCS in Chronic Subjective Severe to Catastrophic Tinnitus With Normal Hearing

Completed
N/A
42
RoW
Transcranial direct current stimulation
Dongtan Sacred Heart Hospital
Tinnitus, Subjective
09/22
09/22
GLOBAL-AKI, NCT05387811: International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project

Completed
N/A
1456
Europe, US, RoW
Crystalloids, albumin, vasoconstrictors, diuretics, renal replacement therapy
Azienda Ospedaliera di Padova
Liver Cirrhosis, Acute Kidney Injury, Hepatorenal Syndrome
09/23
11/23
NCT06712108: Observational Study of Double Cord Blood Transplant

Recruiting
N/A
40
RoW
tranplant
Seoul National University Hospital
Adult Double Unit Cord Blood Transplant
03/30
03/30
NCT02217046: Decrease Implantation Site INFECTION : a Randomized Controlled Trial

Recruiting
N/A
352
RoW
device replacement(pocket capsule removal)
Yong Seog Oh
Infection
08/25
10/25
JAGUAR, NCT05064540: Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Recruiting
N/A
450
US
Alto Abdominal Stent Graft System, FDA Approved EVAR AAA Graft Systems
Endologix
AAA, AAA - Abdominal Aortic Aneurysm
12/28
12/28
Seung, Ki-Bae
IRIS FFR, NCT01366404: Study of the Natural History of FFR Guided Percutaneous Coronary Intervention

Recruiting
N/A
20000
RoW
Seung-Jung Park, CardioVascular Research Foundation, Korea, Abbott Medical Devices
Coronary Artery Disease
04/37
04/37
Choi, Jong Ho
OPTIMAL, NCT03315364 / 2020-000954-86: Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy

Active, not recruiting
2/3
549
Europe, RoW
Oral paclitaxel, Liporaxel®, Paclitaxel injection, Taxol®
Daehwa Pharmaceutical Co., Ltd., Daehwa pharmaceutical Co., Ltd.
Recurrent or Metastatic Breast Cancer
02/24
12/25
Yim, Dong-Seok
No trials found
Han, Seoung-hun
No trials found

Download Options